TRISEQUENS N cpr pell 28 pce

7680400510243 CH-40051 G03FB05 07.08.6.
TRISEQUENS N cpr pell 28 pce
TRISEQUENS N cpr pell 28 pce
TRISEQUENS N cpr pell 28 pce
1 / 3
google

Details

Product number
4005105
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
A) Filmtablette blau: estradiolum 2 mg ut estradiolum hemihydricum 2.07 mg, lactosum monohydricum 36.8 mg, maydis amylum, hydroxypropylcellulosum, talcum, magnesii stearas, Überzug: macrogolum 400, hypromellosum, talcum, E 132, E 171, pro compresso obducto. B) Filmtablette weiss: estradiolum 2 mg ut estradiolum hemihydricum, norethisteroni acetas 1 mg, lactosum monohydricum 36.3 mg, maydis amylum, hydroxypropylcellulosum, talcum, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, pro compresso obducto. C) Filmtablette rot: estradiolum 1 mg ut estradiolum hemihydricum, lactosum monohydricum 37.3 mg, maydis amylum, hydroxypropylcellulosum, talcum, magnesii stearas, Überzug: propylenglycolum, talcum, hypromellosum, E 171, E 172 (rubrum), pro compresso obducto.

Articles (1)

Trisequens N, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/06/2025
Patient information leaflet
Français
11/06/2025
Patient information leaflet
Italien
11/06/2025
Professional SmPC
Allemand
11/06/2025
Professional SmPC
Français
11/06/2025
Professional SmPC
Italien
11/06/2025

Detailed composition

Substance Quantity Type Category
B
2.0 MG Substance Wirkstoff (Principe actif)
A
2.0 MG Substance Wirkstoff (Principe actif)
C
1.0 MG Substance Wirkstoff (Principe actif)
A
2.07 MG Substance WIZUS
B
- Substance WIZUS
C
- Substance WIZUS
C
37.3 MG Substance HBESI
B
1.0 MG Substance Wirkstoff (Principe actif)
A
36.8 MG Substance HBESI
C
- Substance HNIDK
A
- Substance HNIDK
B
36.3 MG Substance HBESI
C
- Substance HNIDK
B
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
C
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
A
- Substance HNIDK
C
- Substance HNIDK
B
- Substance HNIDK
A
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
C
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
C
- Substance HNIDK
C
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
A
- Substance FIMDK
B
- Substance HNIDK
C
- Substance FNIDK
C
- Substance FTODK
A
- Substance FNIDK

Reimbursement information

Public price
CHF 15.10
Specialties list
Yes
Generic
No
SL addition date: 15/03/1978

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
40051
Drug name
Trisequens N, Filmtabletten
Galenic form
FILM
ATC Code
G03FB05
Authorization status
Z
Dispensation category
B
First authorization
17/05/1977
Authorization expiration date
31/12/9999
IT number
07.08.6.
Domain
Human medicine
Field of application
Oestrogen-Gestagen-Substitutionstherapie bei klimakterischen Beschwerden

Packaging details

Description (FR)
TRISEQUENS N cpr pell 28 pce
Description (DE)
TRISEQUENS N Filmtabl 28 Stk
Market launch
21/06/2011
Narcotic (BTM)
No

Other packaging sizes